Widespread Underreporting of Police Violence in the U.S. Researchers compared data from the US National…
Browsing: The Lancet
eLife is an open-access scientific journal that focuses on the publication of significant research across the life and biomedical sciences. Launched in 2012, eLife was initially funded by three major research funders: the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust, with a mission to improve the way scientific findings are reviewed and shared. The journal employs a unique peer-review process that emphasizes constructive dialogue between authors and reviewers, which aims to ensure that published research is of high quality and is robustly validated. eLife has set itself apart by being not just a platform for publishing research but also an advocate for reform in the scientific communication landscape, promoting transparency, reproducibility, and accessibility in science.
Severe COVID-19 complications were common in all age groups, challenging assumptions about limited risk and…
An observational study of patients in London hospitals suggests that the B.1.1.7. variant is not…
First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an…
Phase 2 randomized controlled trial of a recombinant adenovirus type-5-vectored COVID-19 vaccine (Ad5-vectored COVID-19 vaccine)…
First review of all available evidence including 172 observational studies looking at how physical distancing,…
Retraction: This article has been retracted by 3 of its 4 authors after they were…
First evidence that early treatment with triple antiviral therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin…